Navigation Links
Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
Date:12/7/2007

thasone in the Treatment of Previously Untreated Multiple

Myeloma Patients: Impact on Quality-of-Life - Andrew Belch, Cross

Cancer Institute, Edmonton, Alberta, Canada (Abstract 3618)

-- Monday, December 10, 2007, 5:00 p.m.-7:00 p.m., Hall B3 and B4

(Poster Board #:837-III)

-- Pegylated Liposomal Doxorubicin (PLD), Dexamethasone and Low Dose

Thalidomide (DDt): An Active Regimen in the Frontline Therapy for

Multiple Myeloma (MM) - Delva Deauna-Limayo, University of Kansas

Medical Center, Kansas City, KS (Abstract 3619)

-- Monday, December 10, 2007, 5:00 p.m.-7:00 p.m., Hall B3 and B4

(Poster Board #:838-III)

-- Preliminary Results of a Phase II Study of HCVID DOXIL Alternated with

Methotrexate-Cytarabine in Patients with Newly Diagnosed T-Cell

Lymphoma - Barbara Pro, M.D. Anderson Cancer Center, Houston, TX

(Abstract 3456)

-- Monday, December 10, 2007, 5:00 p.m.-7:00 p.m., Hall B3 and B4

(Poster Board #: 675-III)

-- Phase II study of RCHOP with Pegylated Liposomal Doxorubicin (DRCOP)

for Patients > 60 Years Old with Untreated Diffuse Large B Cell

Lymphoma (DLBCL) - Maria Alma Rodriguez, University of Texas M.D.

Anderson Cancer Center, Houston, TX (Abstract 4468 [accepted as

abstract only])

About DOXIL

DOXIL in combination with VELCADE(R) (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma who have not previously received VELCADE and have received at least one prior therapy.

IMPORTANT SAFETY INFORMATION

BOXED WARNINGS

Cardiotoxicity, infusion reaction, myelosuppression, liver impairment, Substitution
-- The use of DOXIL may lead to cardiac toxicity. Myocardial damage may

lead to congestive heart failure and may occur as the total cumulative

dose of doxorubicin HCl approach
'/>"/>

SOURCE Ortho Biotech
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015   InspireMD, Inc.  ("InspireMD" or the ... systems ("EPS"), today announced that it has entered into ... million shares of common stock and warrants to purchase ... in a public offering.  The common stock will be ... share, and each purchaser will receive a warrant to ...
(Date:3/4/2015)... Israël, 4 mars 2015 /PRNewswire/ ... (« RedHill » ou la « Société »), une ... sur les spécialités pharmaceutiques administrés ... stade clinique avancé pour les ... notamment les cancers gastro-intestinaux, a ...
(Date:3/4/2015)... -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced today ... at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give the ... ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation will ... available through the link through June 7, 2015. ...
Breaking Medicine Technology:InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 2RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 3RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 5ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2
... YORK, Jan. 12, 2011 NeoStem, Inc. (NYSE Amex: ... company with operations in the U.S. and China, today announced ... present on Wednesday, January 12, 2011 at the OneMedForum 2011 ... at 11:00 AM PST. Both events will be held in ...
... InstaCare Corp. (OTC Bulletin Board:  ISCR) a ... testing products for the chronically ill, a leading ... and a leading developer of revolutionary cell phone ... company,s Board of Directors has received the initial ...
Cached Medicine Technology:NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011 2NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011 3InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA 2
(Date:3/4/2015)... The defibrillators report provides insights into the growth ... the global market is expected to grow at a ... by 2019. It expects the emerging markets to provide ... established players in the market. , According to the ... at the highest CAGR during the next five years. ...
(Date:3/4/2015)... San Jose, California (PRWEB) March 04, 2015 ... rapidly becoming a worrisome public health issue worldwide. The ... a major economic and social burden in both developed ... cases globally is projected to rise to 1.5 billion, ... About 75% of these patients are forecast to come ...
(Date:3/4/2015)... Developers of FCPX plugins and theme templates ... Final Cut Pro X entitled FCPX Overlays Lens Dirt from ... total control over 6k lens dirt overlays inside Final Cut ... “FCPX Overlays Lens Dirt was professionally designed to add level ... FCPX Overlays Lens Dirt from Pixel Film Studios brings FCPX ...
(Date:3/4/2015)... March 04, 2015 The medical device ... whose management forgot – or ignored or didn't know ... the market based on physician input before proceeding to ... more specifically, founders – become so enamored of an ... question: Will physicians use the device?” says Dr. ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio homeowner ... Court for the Northern District of Ohio against mortgage ... companies Balboa, QBE, and Newport Management. (See Amended Complaint ... The Plaintiff, a Ms. Dolores Gorsuch, says her mortgage ... buy too much insurance at rates that were too ...
Breaking Medicine News(10 mins):Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Pixel Film Studios released a New Overlay Plugin entitled FCPX Overlays Lens Dirt Exclusively for Final Cut Pro X users 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2
... or purchase. , ... New York, ... a global leader in electronic content delivery solutions, today announced ... e-book portal using iPublishCentral ( www.ipublishcentral.com ), an easy-to-implement, cost-effective, ...
... Online health publisher, Healthcommunities.com, Inc., announces recent additions to urologychannel.com, ... in the extensive STD information section, will help ... plans and prevent STD complications. , ... ...
... Under counter ionizer converts to counter top for travel use. , ... Carlsbad, CA (PRWEB) ... mineral water at home or in the office has become a lot ... Ionizers., , , , ,The company today announced the availability of its enhanced ...
... of Spinal Muscular Atrophy has just launched a new Medical ... one of the most highly respected bodies of SMA medical ... proactive, creative, and collaborative leadership on issues that improve the ... new Council will focus on educating families, health care providers, ...
... Attorney General Eric Holder and Health and Human Services Secretary Kathleen ... protect taxpayer dollars on WEDNESDAY, MAY 20, ... Attorney General Eric Holder , Secretary Kathleen Sebelius WHAT: ... 20, 2009 , 1:00 P.M. ET WHERE: ...
... Democrats advance patient-centered CERWASHINGTON, May 19 ... Members of the New Democrat Coalition, Tony Coelho, ... (PIPC), spoke with reporters and announced PIPC,s support ... bill represents an important step forward for patients ...
Cached Medicine News:Health News:American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy 2Health News:American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy 3Health News:Valuable New Resources for Treating Sexually Transmitted Disease (STD) 2Health News:Valuable New Resources for Treating Sexually Transmitted Disease (STD) 3Health News:Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line 2Health News:Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line 3Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 2Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 3Health News:PIPC Supports New Comparative Effectiveness Research (CER) Bill 2
... The Vision5L Digital ... 5- or 7-lead, ... a signal preview,screen. ... using a compact,flash ...
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
... CSV-1000CVA test face is used to evaluate both ... levels (high, 25% and 12.5%) of LogMAR acuity ... face as well as the two spatial frequencies ... most widely used for cataract documentation because eye ...
... is used widely for screening refractive surgery ... from 20/10 to 20/100 and one row ... ,The patient can be easily screened in ... contrast sensitivity. If a contrast sensitivity deficit ...
Medicine Products: